Ockert L, McLennan E, Fox S, Belov K, Hogg C
Sci Rep. 2024; 14(1):15188.
PMID: 38956276
PMC: 11220038.
DOI: 10.1038/s41598-024-66097-8.
Stammnitz M, Gori K, Murchison E
R Soc Open Sci. 2024; 11(4):231875.
PMID: 38633353
PMC: 11022658.
DOI: 10.1098/rsos.231875.
Gallinson D, Kozakiewicz C, Rautsaw R, Beer M, Ruiz-Aravena M, Comte S
Proc Natl Acad Sci U S A. 2024; 121(12):e2307780121.
PMID: 38466855
PMC: 10962979.
DOI: 10.1073/pnas.2307780121.
Petrohilos C, Patchett A, Hogg C, Belov K, Peel E
Sci Rep. 2023; 13(1):12698.
PMID: 37542170
PMC: 10403513.
DOI: 10.1038/s41598-023-39901-0.
Stammnitz M, Gori K, Kwon Y, Harry E, Martin F, Billis K
Science. 2023; 380(6642):283-293.
PMID: 37079675
PMC: 7614631.
DOI: 10.1126/science.abq6453.
Restoring faith in conservation action: Maintaining wild genetic diversity through the Tasmanian devil insurance program.
Farquharson K, McLennan E, Cheng Y, Alexander L, Fox S, Lee A
iScience. 2022; 25(7):104474.
PMID: 35754729
PMC: 9218385.
DOI: 10.1016/j.isci.2022.104474.
Expression of the Nonclassical MHC Class I, Saha-UD in the Transmissible Cancer Devil Facial Tumour Disease (DFTD).
Hussey K, Caldwell A, Kreiss A, Skjodt K, Gastaldello A, Pye R
Pathogens. 2022; 11(3).
PMID: 35335675
PMC: 8953681.
DOI: 10.3390/pathogens11030351.
Challenges of an Emerging Disease: The Evolving Approach to Diagnosing Devil Facial Tumour Disease.
Espejo C, Patchett A, Wilson R, Lyons A, Woods G
Pathogens. 2022; 11(1).
PMID: 35055975
PMC: 8780694.
DOI: 10.3390/pathogens11010027.
The differentiation state of the Schwann cell progenitor drives phenotypic variation between two contagious cancers.
Owen R, Ramarathinam S, Bailey A, Gastaldello A, Hussey K, Skipp P
PLoS Pathog. 2021; 17(11):e1010033.
PMID: 34780568
PMC: 8629380.
DOI: 10.1371/journal.ppat.1010033.
Extracellular vesicle proteomes of two transmissible cancers of Tasmanian devils reveal tenascin-C as a serum-based differential diagnostic biomarker.
Espejo C, Wilson R, Willms E, Ruiz-Aravena M, Pye R, Jones M
Cell Mol Life Sci. 2021; 78(23):7537-7555.
PMID: 34655299
PMC: 11073120.
DOI: 10.1007/s00018-021-03955-y.
Isotopic niche variation in Tasmanian devils with progression of devil facial tumor disease.
Bell O, Jones M, Cunningham C, Ruiz-Aravena M, Hamilton D, Comte S
Ecol Evol. 2021; 11(12):8038-8053.
PMID: 34188870
PMC: 8216929.
DOI: 10.1002/ece3.7636.
Looking like the locals - gut microbiome changes post-release in an endangered species.
Chong R, Grueber C, Fox S, Wise P, Barrs V, Hogg C
Anim Microbiome. 2021; 1(1):8.
PMID: 33499935
PMC: 7807427.
DOI: 10.1186/s42523-019-0012-4.
Evolution and lineage dynamics of a transmissible cancer in Tasmanian devils.
Kwon Y, Gori K, Park N, Potts N, Swift K, Wang J
PLoS Biol. 2020; 18(11):e3000926.
PMID: 33232318
PMC: 7685465.
DOI: 10.1371/journal.pbio.3000926.
The ecology and evolution of wildlife cancers: Applications for management and conservation.
Hamede R, Owen R, Siddle H, Peck S, Jones M, Dujon A
Evol Appl. 2020; 13(7):1719-1732.
PMID: 32821279
PMC: 7428810.
DOI: 10.1111/eva.12948.
Age-related variation in the trophic characteristics of a marsupial carnivore, the Tasmanian devil .
Bell O, Jones M, Ruiz-Aravena M, Hamede R, Bearhop S, McDonald R
Ecol Evol. 2020; 10(14):7861-7871.
PMID: 32760570
PMC: 7391331.
DOI: 10.1002/ece3.6513.
Inbreeding depression in one of the last DFTD-free wild populations of Tasmanian devils.
Gooley R, Hogg C, Fox S, Pemberton D, Belov K, Grueber C
PeerJ. 2020; 8:e9220.
PMID: 32587794
PMC: 7304431.
DOI: 10.7717/peerj.9220.
A Devil of a Transmissible Cancer.
Woods G, Lyons A, Bettiol S
Trop Med Infect Dis. 2020; 5(2).
PMID: 32244613
PMC: 7345153.
DOI: 10.3390/tropicalmed5020050.
Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
Patchett A, Flies A, Lyons A, Woods G
Cell Mol Life Sci. 2020; 77(13):2507-2525.
PMID: 31900624
PMC: 11104928.
DOI: 10.1007/s00018-019-03435-4.
Tracing the rise of malignant cell lines: Distribution, epidemiology and evolutionary interactions of two transmissible cancers in Tasmanian devils.
James S, Jennings G, Kwon Y, Stammnitz M, Fraik A, Storfer A
Evol Appl. 2019; 12(9):1772-1780.
PMID: 31548856
PMC: 6752152.
DOI: 10.1111/eva.12831.
Transmissible Cancers and Immune Downregulation in Tasmanian Devil () and Canine Populations.
Chale R, Ghiam N, McNamara S, Jimenez J
Comp Med. 2019; 69(4):291-298.
PMID: 31387668
PMC: 6733158.
DOI: 10.30802/AALAS-CM-18-000129.